Novartis pays $150 million for heart drug discovered by Ionis

Novartis will pay $150 million to license a heart disease medication discovered by Carlsbad?s Ionis Pharmaceuticals, the Swiss drug giant said Monday.

The experimental drug was co-developed by Ionis with its majority-owned subsidiary Akcea Therapeutics.

Ionis will get half the money, paid for with…